Xofigo 1100 kBq/mL solution for injection, DELTACORTENE 5 mg compresse, ZYTIGA 500 mg film-coated tablets, Xtandi - 40 mg soft capsules, Prednisolone 5mg Tablets
20510
Approved small_molecule active
Quick answer
Xofigo 1100 kBq/mL solution for injection, DELTACORTENE 5 mg compresse, ZYTIGA 500 mg film-coated tablets, Xtandi - 40 mg soft capsules, Prednisolone 5mg Tablets for metastatic castrate resistant prostate cancer (mCRPC) is a Approved program (small_molecule) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- metastatic castrate resistant prostate cancer (mCRPC)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active